Moderna Inc. Stock
€23.12
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Moderna
sharewise wants to provide you with the best news and tools for Moderna, so we directly link to the best financial data sources.
Financials
News
Moderna Stock Looks Ripe for a Short Squeeze
Moderna Inc. (NASDAQ: MRNA) is down 35% in 2025, making it one of the worst-performing stocks among medical stocks and the broader market. Not
Moderna Stock: Conference Presentations May Revitalize Near-Low Shares
Moderna's stock, currently trading near its 52-week low of $23.76, could receive much-needed momentum from the company's upcoming scientific presentations. The biotechnology firm has announced its
Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares
The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market. This is very significant since most of the insider
Moderna Stock: Insider Purchases Spark Remarkable Rally
Moderna shares experienced a significant surge in trading on Thursday, posting a 5.58% gain in European markets and an impressive jump of up to 16% on the NASDAQ. This remarkable performance was
Moderna Stock: Shares Surge After Legal Victory
Moderna shares experienced a remarkable 10.5% rally in NASDAQ trading on Wednesday, climbing to $33.55 from an opening price of $32.58, with peaks reaching $34.18. This positive momentum comes as a
Moderna Stock: Shares Plummet Near 82% From Peak
Moderna's stock experienced significant losses on Friday during NASDAQ trading, falling 0.9% to $30.82 after dipping as low as $30.50 earlier in the session. The biotech company's shares now trade
Moderna Stock: Contract Review Sparks 7.2% Plunge
Moderna shares tumbled 7.2% to $31.17 on Thursday's NASDAQ trading, with the price briefly touching $31.04. The significant drop followed reports that US authorities will review a $590 million
Moderna: A Generational Opportunity for Investors in 2025
As bad as it may look on the charts, Moderna’s (NASDAQ: MRNA) post-COVID let-down and market reset are over. The company stock trades at rock bottom in early 2025 and presents a generational
Moderna Stock: Q4 Loss Exceeds Forecasts, Outlook Disappoints
Moderna's financial performance fell significantly short of market expectations in the fourth quarter of 2023, with the biotechnology company reporting a loss of $2.91 per share, considerably worse
After a Reset Year, Is Moderna Stock Poised for a Comeback?
Biotechnology company Moderna Inc. (NASDAQ: MRNA) gained the spotlight in the medical sector as a leader in the race toward a COVID-19 vaccine. Its messenger RNA (mRNA) technology garnered
Moderna Shares Spike on H5N1 News—What’s Next for Investors?
Shares of Moderna Inc. (NASDAQ: MRNA) surged over 12% after news of the first confirmed death from the H5N1 bird flu in the United States. At one point, the stock had climbed over 14% before
Is it Time to Dump Your Shares of Moderna?
After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune. The coronavirus vaccine maker has seen revenue plummet as demand for
Down 80%, Should You Buy the Dip on Moderna?
A few years ago, Moderna (NASDAQ: MRNA) stock represented the ticket to an investing win. The company brought its coronavirus vaccine from drawing board to commercialization in less than a year and
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid
Equity markets are full of bargains -- stocks that have performed terribly in recent months, whether due to trade-related marketwide issues or company-specific troubles, but could bounce back once
Down 36%, Is Moderna a Buy on the Dip?
In many ways, the pandemic is becoming a faded memory. With that, a major pandemic star -- biotech Moderna (NASDAQ: MRNA) -- also seems to be disappearing from the world's attention. The company's
Market Sell-Off: 2 Stocks Down 17% and 36% This Year to Buy and Hold
What should investors do during a stock-market correction? One great strategy is to go shopping. A bull market will eventually follow the challenging and volatile times we face, and, based on
Where Will Moderna Be in 5 Years?
In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an earnings perspective. As one of the leading coronavirus vaccine companies, the
Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022
The first quarter of 2025 was a tough one. The S&P 500 lost 4.6%, and the Nasdaq Composite lost 10.4%. Following the trend, shares of Moderna (NASDAQ: MRNA) slid 31.8% in the first three months of
FDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy?
Moderna (NASDAQ: MRNA) has gone through its share of ups and downs in recent years, from posting soaring coronavirus vaccine revenue a few years ago to seeing demand for that product sink in the
Why Moderna Stock Is Plummeting Today
Shares of Moderna (NASDAQ: MRNA) are falling on Monday. The company's stock lost 7.9% as of 1:30 p.m. ET and was down as much as 13.9% earlier in the day. The steep decline comes as the S&P 500 and
4 Things You Need to Know if You Buy Moderna Stock Today
It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing a landmark role in tackling the global pandemic in late 2020
Down 93%, Is It Finally Time to Buy Moderna?
As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top of mind back then. A few years ago, Moderna (NASDAQ: MRNA) stock soared on
Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday
A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price surge on Hump Day. The win by the company, best known as the producer of the
Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. But you may be surprised to learn that now you can buy the stock around
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
In the dark days of the coronavirus pandemic, Moderna (NASDAQ: MRNA) was a ray of light in more ways than one. The healthcare company's innovative Spikevax was one of the go-to vaccines that sped to